Navigation Links
Effective mentoring critical to HIV/AIDS research efforts
Date:2/26/2009

An innovative mentoring program at the UCSF-Gladstone Institute for Virology and Immunology Center for AIDS Research is providing vital support for the development of the next generation of HIV/AIDS researchers and clinician scientists.

Described in an article published in the American Journal for Public Health appearing February 26 in the First Look section of the AJPH website, the program focuses on overcoming challenges faced by early-career investigators through several novel mechanisms.

"One key innovation adopted in our program is 'trans' mentoring. In this model, a mentee is paired with a mentor from a research discipline different from the mentee's. For instance, a mentee working in basic science is paired with a mentor who is doing either clinical or behavioral research. One advantage is to lessen potential conflicts of interest between mentee and mentor. Additionally, an important benefit in that it strongly encourages multidisciplinary research," said the article's co-author James S. Kahn, MD, UCSF professor of clinical medicine and co-director of the UCSF-GIVI CFAR's mentoring program.

One of the goals of the CFAR mentoring program is to support and create pathways for multidisciplinary HIV research. The three broad categories that mentors and mentees are divided into are basic research, clinical or translational research, and population or behavioral research.

Another significant innovation in the CFAR program lies in considering the role of the mentor.

"In the past, senior investigators mentored junior researchers without really considering what was necessary for successful mentoring. Our concept is that mentoring is a teachable skill. We focus on and help develop the specific skill set needed by a mentor to best assist an early-career investigator," said Kahn.

Open mentoring is an innovation that the CFAR mentoring program uses to support its goal of retaining early-career inves
'/>"/>

Contact: Jeff Sheehy
jsheehy@ari.ucsf.edu
415-597-8165
University of California - San Francisco
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Physical therapy is effective for management of low-back pain
2. Health and Wellness Programs in a Tight Economy: Why They Are Critical and How to Make Them Effective
3. New bioPoint(TM) ID Nursing Home Visitor Software Cost-Effectively Enhances Security and Peace-of-Mind
4. LENA Foundation Technology Measures Effectiveness of Autism Therapy
5. Steroids ineffective in young children with wheeze
6. EMSI Realigns Internal Divisions for More Effective Focus on Customers
7. What is the most effective therapy for low-dose aspirin induced peptic ulcer?
8. Study shows ultrasound and tPA effective for stroke
9. National Pharmaceutical Council on Economic Stimulus Package: Comparative Effectiveness Research Funding Should Target Improvements in Quality of Patient Care
10. MU researcher demonstrates non-traditional therapy is effective as pain management
11. Absolutely PR's Maggie Holben Participates In CBSA BioBreakfast Expert Panel "How to Garner Media Attention & Effectively Use Public Relations Tactics"

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... arsenic compounds appears to cause oxidative DNA ...rding to a new study published online November 23 ... , Although biomethylation was once believed to ...nhance its toxicity and potentially its carcinogen...ylation in oxidative DNA damage in mice, Michael P...
(Date:11/23/2009)...ealth care professionals enjoy a pay raise for a j...entives for health care performance may actually b...t-care performance ratings for 25 medical groups a...the launch of a statewide pay-for-performance prog...ctors, productivity. , Reporting in the Decem...
(Date:11/23/2009)...rters getting chemo deal with insomnia, study show...- Insomnia and sleep disorders affect more than th...erapy, a rate nearly three times higher than that ... The problem is more common in younger patients an...ersity of Rochester Medical Center researchers, wh...
(Date:11/23/2009)...knesses of drug approval process in United States,...althDay News) -- Problems with the popular arthrit...attack, stroke and death, were known for years bef...t in 2004, a new report says. , Contrary to cl...us side effects were evident in 2000, a year after...
(Date:11/23/2009)...pswithMinorityBanksin Washington D.C. , NewY...bia , S.C. IntendedtoSpurEconomicGrowthandRevit...wswire/--DaVita,thenation,sleadingproviderofdialys...itiativedesignedtocreatejobsandspurrevitalizationi...sinleadingcommunityandminority-ownedbanks.DaVitaha...
Breaking Medicine News(10 mins):Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 2Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 3Health News: Vioxx Problems Known Years Before Recall 2Health News: Vioxx Problems Known Years Before Recall 3Health News: Vioxx Problems Known Years Before Recall 4Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 2Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 3
...o industry best practices, meets new ..., Aug. 21 National health care consulting,practic...pment of a,comprehensive accreditation preparation...sion (URAC)., The URAC assistance program is expe...
...hairman, President & CEO of Blue Shield of Califor...ky Mountain Roundtable on Health, Wellness and,Pre...nvention on Monday,August 25, 2008, 9:30 a.m. MDT ...n which health plans work with employers,and indiv...
... 5,000 list, experiences three-year ...e., Aug. 21 Inc. recently unveiled Vigilan,as No....rowing private,companies in the United States. The...ivers operational management software to assisted ...
...onal,Center today announced that its board member,...nthal, M.D. will lead Meridian,s new Global Health...nitiative of Meridian,s,programs that include worl...y, 79% of people suffering from chronic diseases a...
...atic Cancer,Action Network ( http://www.pancan.org...n a comprehensive way through research, patient su...is saddened by the loss of NFL,Hall of Fame member...President,and CEO. "I know personally the affects ...
... More Than 300 Children Ages 5 - 17, DETROIT, Aug...he United Way 2-1-1 and the United Auto Workers (U... for uninsured and underinsured Detroit,children. ...erested in securing a free vision screening for th...
Other Medicine News:Health News:Halleland Health Consulting Establishes URAC Accreditation Program 2Health News:Blue Shield of California CEO to Speak at Democratic Convention Host Committee's Health Roundtable in Denver 2Health News:Vigilan Recognized as One of the Fastest-Growing Private Companies in the U.S. 2Health News:Former U.S. Assistant Surgeon General, Dr. Susan Blumenthal, to Lead Meridian International Center's Global Health Program 2Health News:The Pancreatic Cancer Action Network is Saddened by the Death of NFL Hall of Fame Member Gene Upshaw 2Health News:Davis Vision, United Way 2-1-1 and the United Auto Workers Team Up to Provide Free Vision Screenings August 25 for Detroit Children 2Health News:Davis Vision, United Way 2-1-1 and the United Auto Workers Team Up to Provide Free Vision Screenings August 25 for Detroit Children 3
(Date:11/23/2009)...LE,Pa.,Nov.23/PRNewswire-FirstCall/--WestPharmaceu...ecompany,sChiefOperatingOfficerMatthewT.Mullarkeyh...andformerChiefOperatingOfficerStevenA.Ellers,58,wi...toprovidemanagerialcontinuityandsupportfollowingMr...tisaglobalmanufacturerofcomponentsandsystemsforinj...
(Date:11/23/2009)...NO,Calif.,Nov.23/PRNewswire-FirstCall/--DURECTCorp...ChiefFinancialOfficer,andJoeStauffer,ChiefMedicalO...HealthCareConferenceonTuesday,December1at3:30pmEas...eHotelinNewYorkCity. ,, (Logo: http://www.newsc...cessthelivepresentationviatheinternet,pleasegototh...
(Date:11/23/2009)...DOAKS,Calif.,Nov.23/PRNewswire-FirstCall/--Amgen(N...ingforBestOverallPipelineandforBestNewDrugforNplat..., TheBestOverallPipelineawardwaspresentedtoAmgen...rketpotentialofthecompany,spipeline,aswellasitsmix...judges,Amgen,spipelineisnotableforitsfocusonunmetc...
Breaking Medicine Technology:DURECT to Present at the 21st Annual Piper Jaffray Health Care Conference 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 3Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 4Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 5Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 6PEER 1 UK Signs 100 Business Hosting Customers in Three Months 60810 1PEER 1 UK Signs 100 Business Hosting Customers in Three Months 60810 2PEER 1 UK Signs 100 Business Hosting Customers in Three Months 60810 3ETEX Corporation Announces Distribution Agreement with Alphatec Spine 60809 1ETEX Corporation Announces Distribution Agreement with Alphatec Spine 60809 2ETEX Corporation Announces Distribution Agreement with Alphatec Spine 60809 3One Catholic Priest and Eleven Other Pro Lifers Arrested for Tearing Up Nancy Pelosis Health Care Bill Outside Her Office 3B See Video Below 60806 1
...eading Attribute in Antibiotic Selection, Accordin..., , MALVERN, Pa. and WALTHAM, Mass. , May 27 Ar...rces find that surveyed physicians will increase p...Johnson & Johnson,s Doribax in the next five y...ns because of their potent broad-spectrum activity...
...red in Dual Cord Blood Transplant for Hematologic ...herapeutics, Inc. announced today that the first...rial of FT1050, a small molecule Stem Cell Modulat...ell (HSC) number and function through its activati...y, which is being conducted at the Dana-Farber Can...
Other Medicine Technology:Carbapenems and Other Agents that Provide Broad-Spectrum Activity are Preferred by Surveyed Physicians for the Treatment of Intra-Abdominal Infections 2Carbapenems and Other Agents that Provide Broad-Spectrum Activity are Preferred by Surveyed Physicians for the Treatment of Intra-Abdominal Infections 3Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support 2Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support 3Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support 4
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: